Tapas Das Selected Research

lysylvaline (Lys-Val)

8/2004

177Lu-DOTA-lanreotide: a novel tracer as a targeted agent for tumor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tapas Das Research Topics

Disease

29	Neoplasms (Cancer) 04/2022 - 02/2003
20	Pain (Aches) 10/2021 - 08/2002
15	Neoplasm Metastasis (Metastasis) 10/2021 - 08/2002
7	Fibrosarcoma 01/2020 - 02/2010
5	Carcinoma (Carcinomatosis) 01/2022 - 11/2006
5	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2016
4	Breast Neoplasms (Breast Cancer) 03/2021 - 07/2005
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022 - 06/2011
3	Liver Neoplasms (Liver Cancer) 05/2009 - 07/2008
2	Cachexia 01/2022 - 10/2009
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2009
2	Inflammation (Inflammations) 01/2018 - 08/2014
2	Thrombocytopenia (Thrombopenia) 01/2016 - 10/2015
2	Anemia 01/2016 - 10/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 10/2010
2	Body Weight (Weight, Body) 10/2015 - 10/2009
2	Lymphoma (Lymphomas) 04/2011 - 02/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Stomatitis 01/2022
1	Mucositis 01/2022
1	Myocarditis (Carditis) 11/2021
1	Ulcerative Colitis 11/2021
1	Insulinoma 11/2019
1	Disseminated Intravascular Coagulation 05/2019
1	Gangrene 05/2019
1	Endophthalmitis (Ophthalmia) 05/2019
1	Chronic Renal Insufficiency 05/2019
1	Mastodynia 01/2018
1	Cognitive Dysfunction 01/2018
1	Atrophy 01/2018

Drug/Important Bio-Agent (IBA)

17	Radioisotopes (Radionuclides)IBA 04/2022 - 12/2004
15	Biological ProductsIBA 01/2020 - 12/2004
11	RadiopharmaceuticalsIBA 01/2020 - 12/2004
10	PorphyrinsIBA 03/2021 - 02/2010
7	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2022 - 08/2004
5	AcidsIBA 12/2013 - 12/2004
4	CurcuminIBA 01/2022 - 10/2009
4	lutetium ethylenediaminetetramethylene phosphonic acidIBA 10/2021 - 03/2014
4	Durapatite (Hydroxylapatite)IBA 01/2016 - 07/2008
4	phosphonic acidIBA 12/2014 - 04/2008
3	Peptide Receptors (Peptide Receptor)IBA 04/2022 - 01/2016
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2022 - 08/2004
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2020
3	1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA 01/2018 - 12/2013
3	Organophosphonates (Phosphonates)IBA 01/2018 - 05/2004
3	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2011 - 08/2004
2	LutetiumIBA 04/2022 - 07/2011
2	Fish OilsIBA 01/2022 - 07/2009
2	177Lu-PSMA-617IBA 04/2021 - 01/2021
2	Intercalating AgentsIBA 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 05/2018 - 09/2017
2	NucleosidesIBA 05/2018 - 09/2017
2	Gemcitabine FDA Link 05/2018 - 09/2017
2	IodineIBA 01/2018 - 05/2007
2	SeleniumIBA 01/2018 - 05/2007
2	AntibodiesIBA 01/2017 - 07/2005
2	177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA 12/2016 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 07/2009
2	MetalsIBA 01/2016 - 09/2008
2	Analgesics (Analgesic Drugs)IBA 10/2015 - 03/2014
2	LigandsIBA 07/2011 - 05/2004
2	Ethiodized Oil (Ethiodol)FDA Link 10/2010 - 05/2009
2	AntioxidantsIBA 07/2009 - 05/2007
1	TeaIBA 01/2022
1	PolyphenolsIBA 01/2022
1	arginyl-glutamineIBA 01/2022
1	QuercetinIBA 01/2022
1	Mesalamine (Mesalazine)FDA LinkGeneric 11/2021
1	gallium 68 PSMA-11IBA 04/2021
1	tetra(4-N-methylpyridyl)porphineIBA 03/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2021
1	Antigen Receptors (Antigen Receptor)IBA 03/2021
1	protein KIBA 03/2021
1	Trastuzumab (Herceptin)FDA Link 03/2021
1	Radium-223IBA 01/2020
1	Aminacrine (Aminoacridine)IBA 01/2020
1	AcridinesIBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019
1	Exenatide (Byetta)FDA Link 11/2019
1	Dacarbazine (DIC)FDA LinkGeneric 05/2019
1	Niacin (Nicotinic Acid)FDA LinkGeneric 04/2019
1	ethylamineIBA 04/2019
1	Chelating AgentsIBA 02/2018
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 02/2018
1	flavan-3-olIBA 01/2018
1	Docosahexaenoic AcidsIBA 01/2018
1	Eicosapentaenoic AcidIBA 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	tositumomab I-131 (Bexxar)FDA Link 01/2017

Therapy/Procedure

23	Therapeutics 04/2022 - 08/2004
6	Palliative Care (Palliative Therapy) 01/2016 - 08/2002
5	Precision Medicine 04/2018 - 01/2016
4	Radiotherapy 11/2019 - 09/2008
3	Castration 04/2021 - 01/2020
1	Renal Dialysis (Hemodialysis) 05/2019
1	Immunotherapy 01/2017